RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 161 filers reported holding RELAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,786 | -32.7% | 19,713 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $246,314 | -18.9% | 19,611 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $303,592 | -3.0% | 18,433 | -12.0% | 0.00% | 0.0% |
| Q4 2022 | $312,993 | -20.6% | 20,950 | +19.1% | 0.00% | -50.0% |
| Q3 2022 | $394,000 | +37.8% | 17,595 | +3.2% | 0.00% | +100.0% |
| Q2 2022 | $286,000 | -60.7% | 17,057 | -29.9% | 0.00% | -50.0% |
| Q1 2022 | $728,000 | -22.2% | 24,327 | -20.2% | 0.00% | 0.0% |
| Q4 2021 | $936,000 | +8.0% | 30,500 | +10.9% | 0.00% | 0.0% |
| Q3 2021 | $867,000 | -25.5% | 27,495 | -13.5% | 0.00% | -33.3% |
| Q2 2021 | $1,163,000 | +36.2% | 31,786 | +28.7% | 0.00% | 0.0% |
| Q1 2021 | $854,000 | -2.2% | 24,706 | +17.6% | 0.00% | 0.0% |
| Q4 2020 | $873,000 | – | 21,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,139,380 | $73,958,000 | 8.86% |
| Darwin Global Management, Ltd. | 782,471 | $27,050,000 | 5.30% |
| EcoR1 Capital, LLC | 3,429,363 | $118,553,000 | 5.26% |
| Foresite Capital Management V, LLC | 400,000 | $13,828,000 | 4.06% |
| Grace Capital | 183,112 | $6,330,000 | 4.03% |
| BVF INC/IL | 2,873,147 | $99,325,000 | 3.72% |
| Casdin Capital, LLC | 3,375,058 | $116,676,000 | 3.48% |
| Fernwood Investment Management, LLC | 185,063 | $6,398,000 | 2.35% |
| Alphabet Inc. | 1,568,486 | $54,222,000 | 2.19% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $964,675,000 | 1.67% |